We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.22B
1-Year Est. Return 16.98%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
AUM
$1.83B
AUM Growth
+$210M
Cap. Flow
+$69M
Cap. Flow %
3.78%
Top 10 Hldgs %
58.7%
Holding
391
New
46
Increased
199
Reduced
122
Closed
15
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MO icon
301
Altria Group
MO
$122B
$283K 0.02%
4,824
+1,129
+31% +$66.3K
JEPQ icon
302
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$39.6B
$283K 0.02%
5,194
-3,057
-37% -$158K
KMB icon
303
Kimberly-Clark
KMB
$36.2B
$280K 0.02%
2,173
+645
+42% +$87.5K
CEG icon
304
Constellation Energy
CEG
$89.9B
$274K 0.02%
+849
New +$225K
A icon
305
Agilent Technologies
A
$38.4B
$273K 0.02%
2,315
-128
-5% -$14.2K
INTU icon
306
Intuit
INTU
$80.6B
$272K 0.01%
+345
New +$233K
XBI icon
307
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$271K 0.01%
3,273
+159
+5% +$12.7K
IVW icon
308
iShares S&P 500 Growth ETF
IVW
$74.2B
$269K 0.01%
2,443
-102
-4% -$10.1K
XME icon
309
State Street SPDR S&P Metals & Mining ETF
XME
$3.92B
$269K 0.01%
3,997
+29
+0.7% +$1.72K
PANW icon
310
Palo Alto Networks
PANW
$289B
$268K 0.01%
1,309
+74
+6% +$13.7K
ADI icon
311
Analog Devices
ADI
$185B
$268K 0.01%
+1,125
New +$234K
VRTX icon
312
Vertex Pharmaceuticals
VRTX
$123B
$267K 0.01%
600
+84
+16% +$38.7K
CART icon
313
Maplebear
CART
$10.9B
$263K 0.01%
5,816
-67
-1% -$2.91K
BLK icon
314
Blackrock
BLK
$168B
$262K 0.01%
250
+28
+13% +$26.5K
SYK icon
315
Stryker
SYK
$127B
$262K 0.01%
663
+35
+6% +$13.1K
INTC icon
316
Intel
INTC
$487B
$261K 0.01%
11,671
+1,299
+13% +$26.9K
EMGF icon
317
iShares Emerging Markets Equity Factor ETF
EMGF
$1.82B
$260K 0.01%
+4,992
New +$241K
DLS icon
318
WisdomTree International SmallCap Dividend Fund
DLS
$1.05B
$260K 0.01%
3,459
-243
-7% -$17K
BMY icon
319
Bristol-Myers Squibb
BMY
$124B
$259K 0.01%
5,601
+63
+1% +$3.09K
IUSB icon
320
iShares Core Universal USD Bond ETF
IUSB
$42.7B
$259K 0.01%
5,594
-554
-9% -$25.3K
BSX icon
321
Boston Scientific
BSX
$66.3B
$258K 0.01%
2,404
+123
+5% +$12.4K
ZS icon
322
Zscaler
ZS
$23.7B
$257K 0.01%
+819
New +$204K
UCON icon
323
First Trust Smith Unconstrained Bond ETF
UCON
$3.28B
$253K 0.01%
10,148
-565
-5% -$13.9K
NUMV icon
324
Nuveen ESG Mid-Cap Value ETF
NUMV
$447M
$252K 0.01%
6,992
+544
+8% +$18.6K
XLI icon
325
State Street Industrial Select Sector SPDR ETF
XLI
$33.5B
$250K 0.01%
1,695
-129
-7% -$17.6K

Similar funds

McAdam LLC's Q2 2025 Portfolio in Review

As of Q2 2025, McAdam LLC held 391 positions worth $1.83B, up 13% from $1.62B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

McAdam LLC deployed $69M of net new capital in Q2 2025, opening 46 new positions and adding to 199 existing holdings. Its largest new stake was AB Tax-Aware Long Municipal ETF: 103,368 shares worth $2.53M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, up from 2.8% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Schwab US Aggregate Bond ETF, an estimated $21.7M trimmed.

  • McAdam LLC's largest Q2 2025 buy was AB Tax-Aware Long Municipal ETF: 103,368 shares worth $2.53M.
  • McAdam LLC added most to JPMorgan Core Plus Bond ETF in Q2 2025, an estimated $31.3M increase.
  • McAdam LLC's biggest Q2 2025 reduction was Schwab US Aggregate Bond ETF, cutting an estimated $21.7M.
  • McAdam LLC fully exited Innovator US Equity Buffer ETF October in Q2 2025, selling an estimated $787K.
  • McAdam LLC's ten largest holdings make up 59% of its $1.83B portfolio in Q2 2025.
  • McAdam LLC opened 46 new positions and closed 15 in Q2 2025.
  • McAdam LLC's portfolio value rose 13% quarter-over-quarter to $1.83B.

Based on McAdam LLC's 13F filing for Q2 2025, filed 15 Jul 2025.